منابع مشابه
Quality assurance of medical software.
Quality assurance is a topical issue within the software industry, and various methodological solutions aimed at improving software quality have been proposed. Medical software is generally deemed safety-critical and, as such, should be subject to control procedures exceeding those applicable to general-purpose software. The user/purchaser of medical equipment has an important part to play in t...
متن کاملQuality assurance of medical ontologies.
OBJECTIVE To review the literature concerning the quality assurance of medical ontologies. METHODS scholar.google.com was searched using the search strings (+ontology +"quality assurance") and (+ontology +"evaluation/evaluating"). Relevant publications were selected by manual review. Other work already familiar to the author, or suggested by other researchers contacted by the author, were inc...
متن کاملMedical student exposure to and attitudes about pharmaceutical companies.
PURPOSE Medical students are at-risk to the influence of pharmaceutical company (Pharma) marketing. As interactions with the industry come under increasing scrutiny and regulation, previous studies on student-Pharma relations no longer may be accurate. This study assessed students' attitudes toward and interactions with Pharmas at the University of Wisconsin School of Medicine and Public Health...
متن کاملBeyond "medical tourism": Canadian companies marketing medical travel
BACKGROUND Despite having access to medically necessary care available through publicly funded provincial health care systems, some Canadians travel for treatment provided at international medical facilities as well as for-profit clinics found in several Canadian provinces. Canadians travel abroad for orthopaedic surgery, bariatric surgery, ophthalmologic surgery, stem cell injections, "Liberat...
متن کاملMedical journals and pharmaceutical companies: uneasy bedfellows.
One of my first experiences of the relation between medical journals and pharmaceutical companies occurred in the early 1980s after the BMJ had published papers suggesting that a new non-steroidal anti-inflammatory drug, benoxaprofen, might have serious side effects. We were visited by three stern men from Eli Lilly, the makers of the drug. Tony Smith, the deputy editor, conducted the meeting a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet
سال: 1843
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(02)75249-5